IFNB1 and myeloid sarcoma: In a similar vein, another recent investigation examined the shifts in gut microbiota among 60 subjects, comprising 39 MS patients and 21 healthy controls, both before and after undergoing a DMT, which included either IFN‐β1 or TER.